Stay updated on Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial page.

Latest updates to the Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section listing participating sites by state/province, including United States states and Canadian provinces.SummaryDifference1%

- Check54 days agoChange DetectedPublication notes now clarify that PubMed publications are automatically filled for the study. The revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page no longer displays the government funding/operating-status notice; study content and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedNo significant additions or deletions were detected in the page content between versions; the study overview, objectives, eligibility criteria, and outcomes sections appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check104 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data freshness issues due to funding lapse and directing users to official status pages; removed the previous v3.1.0 tag.SummaryDifference1%

Stay in the know with updates to Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial page.